Travis Steed Analyst PerformanceAnalyst at Bank of AmericaTravis Steed is a stock analyst at Bank of America focused in the medical sector, covering 17 publicly traded companies. Over the past year, Travis Steed has issued 17 stock ratings, including buy, hold, and sell recommendations. While full access to Travis Steed's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Travis Steed's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings30 Last 8 YearsBuy Recommendations56.67% 17 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution30RatingsDistribution of strong buy, buy, hold, and sell ratings by Travis Steed.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.7%17 ratings Hold40.0%12 ratings Sell3.3%1 ratingsOut of 30 total stock ratings issued by Travis Steed at Bank of America, the majority (56.7%) have been Buy recommendations, followed by 40.0% Hold and 3.3% Sell.Best & Worst CallsBest Call000.0%PENMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AXGNJan 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ58.8% of companies on NASDAQ10 companiesNYSE41.2% of companies on NYSE7 companiesTravis Steed, an analyst at Bank of America, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies94.1%Manufacturing1 company5.9%Travis Steed of Bank of America specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS8 companies47.1%MED PRODUCTS4 companies23.5%MEDICAL SERVICES2 companies11.8%MED/DENTAL - SUPP2 companies11.8%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company5.9% Travis Steed's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBBNXBeta Bionics5/18/2026Lower Price Target$9.19$11.00Neutral$0.0000.00% ROIDXCMDexCom5/18/2026Lower Price Target$64.24$80.00Buy$0.0000.00% ROITNDMTandem Diabetes Care5/18/2026Lower Price Target$13.55$25.00Neutral$0.0000.00% ROIPODDInsulet5/18/2026Lower Price Target$152.67$208.00Buy$0.0000.00% ROIMMEDMiniMed Group5/18/2026Lower Price Target$11.04$20.00Buy$0.0000.00% ROIISRGIntuitive Surgical5/18/2026Lower Price Target$436.99$520.00Buy$0.0000.00% ROIEMBCEmbecta5/18/2026Lower Price Target$3.02$3.00Underperform$0.0000.00% ROICNMDCONMED5/18/2026Lower Price Target$36.37$40.00Neutral$0.0000.00% ROIABTAbbott Laboratories4/17/2026Lower Price Target$95.08$120.00Buy$0.0000.00% ROIMMEDMiniMed Group3/31/2026Initiated Coverage$14.35$27.00Buy$0.0000.00% ROITNDMTandem Diabetes Care2/20/2026Upgrade$18.52$30.00Neutral$0.0000.00% ROIBBNXBeta Bionics1/9/2026Downgrade$31.99Neutral$0.0000.00% ROIBBNXBeta Bionics1/5/2026Boost Price Target$29.25$33.00Buy$0.0000.00% ROIPENPenumbra1/5/2026Boost Price Target$309.44$370.00Buy$0.0000.00% ROIBDXBecton, Dickinson and Company1/5/2026Boost Price Target$194.73$207.00Neutral$0.0000.00% ROICNMDCONMED12/8/2025Lower Price Target$40.16$52.00Neutral$0.0000.00% ROIMASIMasimo11/17/2025Initiated Coverage$151.12$162.00Neutral$0.0000.00% ROIBDXBecton, Dickinson and Company4/7/2025Lower Price Target$205.77$261.00Overweight$000.0000.00% ROIPENPenumbra3/14/2025Initiated Coverage$260.75$320.00Buy$000.0000.00% ROIABTAbbott Laboratories3/10/2025Boost Price Target$138.84$150.00Buy$000.0000.00% ROISOLVSolventum2/26/2025Boost Price Target$83.74$85.00Neutral$00.0000.00% ROIBDXBecton, Dickinson and Company2/14/2025Boost Price Target$224.98$279.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
